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849the high ECV subjects is therefore likely to contribute
to the higher calculated ECV with this method. This is
most striking for the HCM-LGE subgroup compared
with the HCM-remote group and raises the question
of whether the observed differences in blood T1
between groups do not reﬂect different equilibrium
states between blood and myocardium according to
the study groups.
Multiple factors may contribute to the higher blood
T1 with the bolus approach in subjects with disease.
Heart rate or ﬂow-dependent variations in blood
inversion could lower the accuracy of T1 measure-
ment (4). Altered blood clearance through renal
impairment and synovial third-space penetration of
contrast may also act as confounders. More complex
examinations in disease may produce lower image
quality, altering intrastudy ECV reproducibility as a
factor of time (5).
We are aware of the complex nature of myocardial
T1 measure, of multiple factors interfering with ECV
calculation and we much appreciate the transparency
and completeness of data provided. We would like to
know the authors’ interpretation of the blood T1 data.
We believe this is an issue of practical interest in a
ﬁeld expected to provide a key biomarker in cardiac
disease in the future.Andrei Codreanu, MD*
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90–7.REPLY: Effects of Blood T1 on
Extracellular Volume CalculationWe thank Dr. Codreanu and colleagues for their inter-
est in our paper (1). This study explored whether extra-
cellular volume fraction (ECV) measurement using a
bolus-only approach was equivalent to the (cumber-
some and time-consuming) primed infusion protocol.
If so, it takes this promising novel biomarker a
step closer to routine clinical applicability (2). We
conﬁrmed no apparent detriment to the relationship
with collagen volume fraction in low ECV states,
but in high ECV states, the bolus-only approach
measured the ECV higher.
How to scrutinize this discrepancy? First, although
reasonable, it is an assumption that the primed infu-
sion technique is the truth standard. Second, given
sufﬁcient time, the infusion approach needs no
priming bolus; the blood gadolinium (Gd) concentra-
tions will gradually rise to an infusion rate:renal
clearance equilibrium. We, however, use a primed
infusion with ﬁxed bolus (per kilogram), ﬁxed delay,
and ﬁxed infusion rate (per kilogram). The choice of
these affects whether the 15-min T1 is higher than,
equal to, or lower than the equilibrium T1. Here in
high ECV states, the 15-min pseudoequilibrium T1 was
higher than the infusion equilibrium (i.e., Gd blood
concentrations climb to equilibrium). Possible expla-
nations include factors that affect peak blood con-
centration, any of the Gd decay rate constants (blood
redistribution, tissue distribution and renal function),
and ﬁnal resting equilibrium (renal function and body
composition). Our suspicion is that high ECV patients
have worse renal function and are generally leaner
(thus proportionally overdosed with Gd).
Does this matter? For an infusion approach, a
bolus þ delay þ infusion rate normogram based on
pharmacodynamic/kinetic modeling, lean body mass,
and renal function could be constructed, aiming for
an identical equilibrium Gd concentration. Provided
the T1 mapping sequence sensitivity is stable over
the clinical range of T1 measured and provided Gd
concentrations are not so high that relaxation of
intracellular water ceases to be within the fast
exchange limit, individualization is probably not
necessary. Other possible approaches include serial
time point measurements to create a curve (the
Jerosch-Herold method) (3) and a bolus-only approach
with serial measurement and ECV calculation at a
ﬁxed blood T1 or Gd concentration (rather ﬁxed time
post bolus).
It is clear we do not understand all the issues.
Currently, however, our interpretation is that,
excepting amyloidosis research (tracking change over
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850time or with therapy when patients may change
signiﬁcantly, e.g., effusions, renal function, body
composition), the bolus-only approach is reasonable;
that is, if there is reduced accuracy or precision, it is
outweighed by the convenience of the approach.Steven K. White, BSc, MBChB
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